593 related articles for article (PubMed ID: 32610099)
1. Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders.
Soo SK; Rudich PD; Traa A; Harris-Gauthier N; Shields HJ; Van Raamsdonk JM
Mech Ageing Dev; 2020 Sep; 190():111297. PubMed ID: 32610099
[TBL] [Abstract][Full Text] [Related]
2. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S; McDermott MP; Shefner J; Stanislaw C; Abrahams S; Cosentino S; Andersen PM; Finkel RS; Granit V; Grignon AL; Rohrer JD; McMillan CT; Grossman M; Al-Chalabi A; Turner MR;
Brain; 2022 Mar; 145(1):27-44. PubMed ID: 34677606
[TBL] [Abstract][Full Text] [Related]
3. Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.
Ciurea AV; Mohan AG; Covache-Busuioc RA; Costin HP; Glavan LA; Corlatescu AD; Saceleanu VM
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445986
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
[TBL] [Abstract][Full Text] [Related]
6. Ageing and neurodegenerative diseases.
Hung CW; Chen YC; Hsieh WL; Chiou SH; Kao CL
Ageing Res Rev; 2010 Nov; 9 Suppl 1():S36-46. PubMed ID: 20732460
[TBL] [Abstract][Full Text] [Related]
7. Genetically modified pig models for neurodegenerative disorders.
Holm IE; Alstrup AK; Luo Y
J Pathol; 2016 Jan; 238(2):267-87. PubMed ID: 26446984
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
[TBL] [Abstract][Full Text] [Related]
9. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.
Mulligan VK; Chakrabartty A
Proteins; 2013 Aug; 81(8):1285-303. PubMed ID: 23508986
[TBL] [Abstract][Full Text] [Related]
10. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy.
Tan CC; Yu JT; Tan MS; Jiang T; Zhu XC; Tan L
Neurobiol Aging; 2014 May; 35(5):941-57. PubMed ID: 24360503
[TBL] [Abstract][Full Text] [Related]
11. Beneficial Effects of Exogenous Ketogenic Supplements on Aging Processes and Age-Related Neurodegenerative Diseases.
Kovács Z; Brunner B; Ari C
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34206738
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Disease: astrocytes in neurodegenerative disease.
Maragakis NJ; Rothstein JD
Nat Clin Pract Neurol; 2006 Dec; 2(12):679-89. PubMed ID: 17117171
[TBL] [Abstract][Full Text] [Related]
13. Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design.
Sehgal SA; Hammad MA; Tahir RA; Akram HN; Ahmad F
Curr Neuropharmacol; 2018; 16(6):649-663. PubMed ID: 29542412
[TBL] [Abstract][Full Text] [Related]
14. Genetic neurodegenerative diseases: the human illness and transgenic models.
Price DL; Sisodia SS; Borchelt DR
Science; 1998 Nov; 282(5391):1079-83. PubMed ID: 9804539
[TBL] [Abstract][Full Text] [Related]
15. Genetic classification of primary neurodegenerative disease.
Hardy J; Gwinn-Hardy K
Science; 1998 Nov; 282(5391):1075-9. PubMed ID: 9804538
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical correlation between major depressive disorder and neurodegenerative diseases.
Réus GZ; Titus SE; Abelaira HM; Freitas SM; Tuon T; Quevedo J; Budni J
Life Sci; 2016 Aug; 158():121-9. PubMed ID: 27370938
[TBL] [Abstract][Full Text] [Related]
17. Effects of lifespan-extending interventions on cognitive healthspan.
Culig L; Sahbaz BD; Bohr VA
Expert Rev Mol Med; 2022 Nov; 25():e2. PubMed ID: 36377361
[TBL] [Abstract][Full Text] [Related]
18. Effects of exercise on sleep in neurodegenerative disease.
Memon AA; Coleman JJ; Amara AW
Neurobiol Dis; 2020 Jul; 140():104859. PubMed ID: 32243913
[TBL] [Abstract][Full Text] [Related]
19. Mitophagy in Alzheimer's Disease and Other Age-Related Neurodegenerative Diseases.
Cai Q; Jeong YY
Cells; 2020 Jan; 9(1):. PubMed ID: 31936292
[TBL] [Abstract][Full Text] [Related]
20. Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes.
Calabrese V; Guagliano E; Sapienza M; Panebianco M; Calafato S; Puleo E; Pennisi G; Mancuso C; Butterfield DA; Stella AG
Neurochem Res; 2007; 32(4-5):757-73. PubMed ID: 17191135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
